Vabysmo 6 mg (Faricimab SOLUTION) 6 MG

VABYSMO 6 MG is an intravitreal solution containing faricimab, used for treating eye conditions. This medication is designed to support retinal health and may help manage certain vision-related issues.

Strength

6 MG

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VABYSMO 6 MG is primarily used for the treatment of eye conditions that affect the retina. Faricimab, the active ingredient, is intended to support retinal health and may help manage symptoms associated with retinal diseases. This solution is administered via intravitreal injection, directly into the eye, to target specific areas of concern.

Side Effects

Common effects of VABYSMO 6 MG may include temporary vision disturbances, eye redness, or discomfort following administration. Some individuals might experience mild irritation or inflammation at the injection site. These effects are generally short-lived and should be monitored by a healthcare professional.

Precautions & Warnings

VABYSMO 6 MG should be handled with care and administered by a trained healthcare professional. It is important to follow all safety guidelines provided with the medication. Patients should inform their healthcare provider about any existing eye conditions or allergies before starting treatment.

Avoid Interactions

VABYSMO 6 MG may interact with other medications, particularly those that affect the eyes or immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this solution.

Frequently Asked Questions

VABYSMO 6 MG is used for treating eye conditions that affect the retina, supporting retinal health and managing related symptoms.

VABYSMO 6 MG is administered via intravitreal injection, directly into the eye, by a trained healthcare professional.

Common effects may include temporary vision disturbances, eye redness, or discomfort following administration.

Individuals with certain eye conditions or allergies should consult a healthcare provider before using VABYSMO 6 MG.

Yes, VABYSMO 6 MG may interact with other medications, particularly those affecting the eyes or immune system.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.